Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(13%)
Results Posted
67%(2 trials)

Phase Distribution

Ph phase_4
2
25%
Ph not_applicable
5
63%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 4Post-market surveillance
2(28.6%)
N/ANon-phased studies
5(71.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)
Other(3)

Detailed Status

unknown3
Completed3
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (28.6%)
N/A5 (71.4%)

Trials by Status

unknown338%
completed338%
withdrawn113%
recruiting113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
PROCEDURE
Total Trials
8